Yanping Li
Yunnan Key Laboratory Of Dai And Yi Medicines
Kunming, 650500, China
Kunming, 650500, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Correction: New 1,2,3-triazole-linked (±)-agrimonolide derivatives as anti-ulcerative colitis agents inhibiting JAK1/STAT3 pathways.
Journal: Molecular diversity
Published: August 07, 2026
Exploration of novel costunolide derivatives bearing indole/indoline as anti-ulcerative colitis agents by targeting JAK2-STAT3 pathways.
Journal: Bioorganic chemistry
Published: January 20, 2026
Unveiling the multifaceted benefits of Simiao Pill in ulcerative colitis: Integrative analysis of signaling pathways, gut microbiota, and lipid metabolism.
Journal: Journal of ethnopharmacology
Published: December 11, 2024
Formononetin suppresses colitis-associated colon cancer by targeting lipid synthesis and mTORC2/Akt signaling.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: December 04, 2024
Unveiling the hepatoprotective mechanisms of Desmodium heterocarpon (L.) DC: Novel flavonoid identification and Keap1/Nrf2 pathway activation.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: June 18, 2024
Development of new dehydrocostuslactone derivatives for treatment of atopic dermatitis via inhibition of the NF-κB signaling pathway.
Journal: RSC medicinal chemistry
Published: April 27, 2024
New meroterpenoids and polyketides from the endophytic fungus Paraphaeosphaeria sp. C-XB-J-1 and their anti-inflammatory and SARS-CoV-2 Mpro inhibitory activities.
Journal: Bioorganic chemistry
Published: January 31, 2024
Antifungal evaluation of quinoline-chalcone derivatives combined with FLC against drug-resistant Candida albicans.
Journal: Bioorganic & medicinal chemistry letters
Published: January 11, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026